Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Positron emission tomography (PET) for cholangiocarcinoma.

Literature DB >> 18773069

Positron emission tomography (PET) for cholangiocarcinoma.

S Breitenstein¹, C Apestegui, P-A Clavien.

Abstract

The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%. PET, and particularly PET-CT, improves the results and impacts on the oncological management in CCA compared with other imaging modalities. Therefore, PET-CT is recommended in the preoperative staging of intrahepatic (strength of recommendation: moderate) and extrahepatic (strength of recommendation: low) CCA.

Entities: Disease Gene

Keywords: Cholangiocarcinoma; computed tomography (CT); positron emission tomography (PET)

Year: 2008 PMID： 18773069 PMCID： PMC2504390 DOI： 10.1080/13651820801992583

Source DB: PubMed Journal: HPB (Oxford) ISSN： 1365-182X Impact factor: 3.647

10 in total

1. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.

Authors: Thomas F Hany; Hans C Steinert; Gerhard W Goerres; Alfred Buck; Gustav K von Schulthess
Journal: Radiology Date: 2002-11 Impact factor: 11.105

2. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors: Y Fong; W Jarnagin; L H Blumgart
Journal: Ann Surg Date: 2000-10 Impact factor: 12.969

3. FDG PET in the diagnosis of hilar cholangiocarcinoma.

Authors: A Fritscher-Ravens; K H Bohuslavizki; D C Broering; L Jenicke; H Schäfer; R Buchert; X Rogiers; M Clausen
Journal: Nucl Med Commun Date: 2001-12 Impact factor: 1.690

4. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

Authors: Henrik Petrowsky; Peer Wildbrett; Daniela B Husarik; Thomas F Hany; Simona Tam; Wolfram Jochum; Pierre-Alain Clavien
Journal: J Hepatol Date: 2006-04-19 Impact factor: 25.083

5. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

Authors: R Kluge; F Schmidt; K Caca; H Barthel; S Hesse; P Georgi; A Seese; D Huster; F Berr
Journal: Hepatology Date: 2001-05 Impact factor: 17.425

6. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

Authors: Takashi Kato; Eriko Tsukamoto; Yuji Kuge; Chietsugu Katoh; Toshikazu Nambu; Aichiro Nobuta; Satoshi Kondo; Masahiro Asaka; Nagara Tamaki
Journal: Eur J Nucl Med Mol Imaging Date: 2002-06-01 Impact factor: 9.236

7. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Authors: Young-Jin Kim; Mijin Yun; Woo Jung Lee; Kyung Sik Kim; Jong Doo Lee
Journal: Eur J Nucl Med Mol Imaging Date: 2003-08-07 Impact factor: 9.236

8. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.

Authors: Yoshikazu Morimoto; Yasuhiro Tanaka; Toshinori Ito; Masaaki Nakahara; Hiroyuki Nakaba; Toshiro Nishida; Masahiro Fujikawa; Toshikazu Ito; Shigetaka Yamamoto; Toru Kitagawa
Journal: J Hepatobiliary Pancreat Surg Date: 2003

9. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Authors: Hossein Jadvar; Robert W Henderson; Peter S Conti
Journal: J Comput Assist Tomogr Date: 2007 Mar-Apr Impact factor: 1.826

10. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.

Authors: Chang Mo Moon; Seungmin Bang; Jae Bock Chung; Seung Woo Park; Si Young Song; Mijin Yun; Jong Doo Lee
Journal: J Gastroenterol Hepatol Date: 2007-10-10 Impact factor: 4.029

10 in total

14 in total

Review 1. [Liver transplantation for hilar cholangiocarcinoma].

Authors: F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal: Chirurg Date: 2012-03 Impact factor: 0.955

2. Hilar cholangiocarcinoma: expert consensus statement.

Authors: John C Mansour; Thomas A Aloia; Christopher H Crane; Julie K Heimbach; Masato Nagino; Jean-Nicolas Vauthey
Journal: HPB (Oxford) Date: 2015-08 Impact factor: 3.647

3. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion.

Authors: Alastair L Young; Tsuyoshi Igami; Yoshiki Senda; Robert Adair; Shahid Farid; Giles J Toogood; K Rajendra Prasad; J Peter A Lodge
Journal: HPB (Oxford) Date: 2011-07 Impact factor: 3.647

Review 4. Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors: Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal: Hepatobiliary Surg Nutr Date: 2017-04 Impact factor: 7.293

Review 5. [Treatment approach for gall bladder and extrahepatic bile duct cancer].

Authors: S Manekeller; J C Kalff
Journal: Chirurg Date: 2018-11 Impact factor: 0.955

6. Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy.

Authors: Danupon Nantajit; Pornwaree Trirussapanich; Sunanta Rojwatkarnjana; Kamonwan Soonklang; Poompis Pattaranutraporn; Kanyanee Laebua; Sasikarn Chamchod
Journal: Mol Clin Oncol Date: 2016-11-02

7. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.

Authors: Wolf-Rudiger Matull; Dipok K Dhar; Lakshmana Ayaru; Neomal S Sandanayake; Michael H Chapman; Aruna Dias; John Bridgewater; George J M Webster; Jin J Bong; Brian R Davidson; Stephen P Pereira
Journal: Liver Int Date: 2010-09-16 Impact factor: 5.828